Thor Medical ASA (OSL:TRMED)
kr 1.018 0.014 (1.39%) Market Cap: 239.09 Mil Enterprise Value: 210.39 Mil PE Ratio: 0 PB Ratio: 0.93 GF Score: 39/100

Nordic Nanovector ASA M&A Call Transcript

Nov 10, 2022 / 09:00AM GMT
Release Date Price: kr1.18 (-12.59%)
Jan Hendrik Egberts
Nordic Nanovector ASA - Independent Chairman of the Board

Good morning, ladies and gentlemen. Welcome to the Nordic Nanovector and APIM joint webcast where we will discuss the merger between our 2 companies. My name is Jan Egberts. I'm the Chairman of the Board of Nordic Nanovector. Together with me here are Malene Brondberg, our Interim CEO and CFO; as well as Kostas Alevizopoulos, I hope I pronounced his name correctly, the CEO and CFO of APIM Therapeutics.

I will first take you a little bit through the headline of the transaction, and then Malene will take you through some of the implications on the Nordic Nanovector side. Thereafter, Kostas will tell you a little bit about APIM Therapeutics and give you a bit of an overview on the company.

So first of all, I want to give you a couple of comments. I realize that many of you had a desire for more information over the past couple of months during the aftermath of the PARADIGME situation and the strategic review that we conducted together with the help of Carnegie. Unfortunately, due to the very sensitive nature,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot